Synthesis 2012; 44(11): 1667-1671
DOI: 10.1055/s-0031-1291006
paper
© Georg Thieme Verlag Stuttgart · New York

Oxidative Cyclization Reactions of Tryptamine Utilizing Hypervalent Iodobenzene in Routes for Pyrroloindole Alkaloid Synthesis

Daichi Kajiyama
Department of Chemistry, Faculty of Science and Technology, Keio University, Hiyoshi 3-14-1, Kohoku-ku, Yokohama 223-8522, Japan , Fax: +81(45)5661717   Email: nisiyama@chem.keio.ac.jp
,
Tsuyoshi Saitoh
Department of Chemistry, Faculty of Science and Technology, Keio University, Hiyoshi 3-14-1, Kohoku-ku, Yokohama 223-8522, Japan , Fax: +81(45)5661717   Email: nisiyama@chem.keio.ac.jp
,
Satoshi Yamaguchi
Department of Chemistry, Faculty of Science and Technology, Keio University, Hiyoshi 3-14-1, Kohoku-ku, Yokohama 223-8522, Japan , Fax: +81(45)5661717   Email: nisiyama@chem.keio.ac.jp
,
Shigeru Nishiyama*
Department of Chemistry, Faculty of Science and Technology, Keio University, Hiyoshi 3-14-1, Kohoku-ku, Yokohama 223-8522, Japan , Fax: +81(45)5661717   Email: nisiyama@chem.keio.ac.jp
› Author Affiliations
Further Information

Publication History

Received: 31 March 2012

Accepted after revision: 10 April 2012

Publication Date:
10 May 2012 (online)


Abstract

Oxidative cyclization of N-acetyltryptamine by using iodobenzene­ diacetate (PIDA) provided the corresponding 1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-3a-ol derivative, which could be derivatized following appropriate protection of the two amino and tert-hydroxyl groups. The facile one-pot procedure for cyclization and introduction of the oxygen functionality was applied in concise routes for the synthesis of the natural products CPC-1 and debromoflustraminol B.

 
  • References

  • 1 For a review, see: Ruiz-Sanchis P, Savina SA, Albericio F, Álvarez M. Chem.–Eur. J. 2011; 17: 1388
    • 2a Kamenecka TM, Danishefsky SJ. Angew. Chem. Int. Ed. 1998; 37: 2995
    • 2b Baran PS, Cuerrero CA, Corey EJ. J. Am. Chem. Soc. 2003; 125: 5628
    • 2c Depew KM, Marsden SP, Zatorska D, Zatorski A, Bornmann WG, Danishefsky SJ. J. Am. Chem. Soc. 1999; 121: 11953
    • 2d Ley SV, Cleator E, Hewitt PR. Org. Biomol. Chem. 2003; 1: 3492
    • 2e Nakagawa M, Kaneko T, Yamaguchi H, Kawashima T, Hino T. Tetrahedron 1974; 30: 2591
    • 2f Liu K, Wen P, Liu J, Huang G. Synthesis 2010; 3623
    • 3a Braun NA, Bray JD, Ciufolini MA. Tetrahedron Lett. 1999; 40: 4985
    • 3b Padwa A, Stengel T. Org. Lett. 2002; 4: 2137
  • 4 Takayama H, Misawa K, Okada N, Ishikawa H, Kitajima M, Hatori Y, Murayama T, Wongseripipatana S, Tashima K, Matsumoto K, Horie S. Org. Lett. 2006; 8: 5705
    • 5a Inoue K, Ishikawa Y, Nishiyama S. Org. Lett. 2010; 12: 436
    • 5b Kajiyama D, Ishikawa Y, Nishiyama S. Tetrahedron 2010; 66: 9779
    • 5c Early report: Kishi Y, Nakatsuka S, Fukuyama T, Havel M. J. Am. Chem. Soc. 1973; 95: 6493
  • 7 Oxidations of tryptamines 8 that did not possess an acetamide group provided none of the desired cyclized products 9 (Scheme 3)
  • 8 Kitajima M, Mori I, Arai K, Kogure N, Takayama H. Tetrahedron Lett. 2006; 47: 3199
  • 9 For flustraminol B, see: Carlé JS, Christophersen C. J. Org. Chem. 1981; 46: 3440